Guardant Health Guardant Health GH $ 150.99 $6.92 4.8% 24% IBD Stock Analysis Stock is rebounding from 50-day support after late-May breakout. A move above the 21-day exponential line could provide an alternative entry. IBD Composite Rating 66/99 Industry Group Ranking 11/197 Emerging Pattern Pullback Pullback A stock may pull back after a breakout, often to the 50-day line. A…

Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8

Related news